Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Mathai

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Annals of the American Thoracic Society|October 16, 2020
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Roham T Zamanian, Vinicio A de Jesus Perez, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2025
Metabolomic Evidence of Biological Overlap with HFpEF in a Subset of Pulmonary Arterial HypertensionYogesh N V Reddy, Aneesh K Asokan, Robert P Frantz, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2018
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium ReportJason M Elinoff, Richa Agarwal, Christopher F Barnett, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary HypertensionIvor W Clinton, Julie C Coursen, Darin T Rosen, et al.
Chest|April 13, 2025
Echocardiographic Parameters Enhance Risk Prediction Scores in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics NetworkMonica Mukherjee, Vivek P Jani, Ryan Osgueritchian, et al.
Circulation. Cardiovascular Imaging|December 18, 2024
Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease from the PVDOMICS StudyMonica Mukherjee, Stephen C Mathai, Christine Jellis, et al.
Journal of the American Heart Association|May 22, 2025
Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular DiseaseDarin T Rosen, Todd M Kolb, Stephen C Mathai, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 3, 2023
Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertensionCatherine E Simpson, Anjira S Ambade, Robert Harlan, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Annals of the American Thoracic Society|October 16, 2020
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Roham T Zamanian, Vinicio A de Jesus Perez, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2025
Metabolomic Evidence of Biological Overlap with HFpEF in a Subset of Pulmonary Arterial HypertensionYogesh N V Reddy, Aneesh K Asokan, Robert P Frantz, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2018
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium ReportJason M Elinoff, Richa Agarwal, Christopher F Barnett, et al.
Pulmonary Circulation|October 21, 2021
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)Jasleen Minhas, Sai Prasanna Narasimmal, Todd M Bull, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary HypertensionIvor W Clinton, Julie C Coursen, Darin T Rosen, et al.
Chest|April 13, 2025
Echocardiographic Parameters Enhance Risk Prediction Scores in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics NetworkMonica Mukherjee, Vivek P Jani, Ryan Osgueritchian, et al.
Circulation. Cardiovascular Imaging|December 18, 2024
Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease from the PVDOMICS StudyMonica Mukherjee, Stephen C Mathai, Christine Jellis, et al.
Journal of the American Heart Association|May 22, 2025
Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular DiseaseDarin T Rosen, Todd M Kolb, Stephen C Mathai, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 3, 2023
Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertensionCatherine E Simpson, Anjira S Ambade, Robert Harlan, et al.
Pulmonary Circulation|December 25, 2023
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working GroupKellie Morland, Christian Gerges, Jean Elwing, et al.
Pageof 22